US STOCK
CVS Stock Analysis
US stocks · market data · technical indicators
CVS HEALTH CORPORATION
CVSUS stocksQuote delayed 15 min
9/11 下午10:50 updated
$94.80
-0.49-0.51%
Open
$95.78
High
$96.41
Low
$94.49
Volume
39.92萬
CVS price history
-0.50%Open
94.99
Latest
94.52
High
97.60
Low
92.90
Average
94.89
Advertisement
AI Composite Technical Analysis
BetaFormula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
AI Score45
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
HoldCurrent Price$94.8
Target Price$90.06
Change %-0.51%
Institutional
Net Selling
Foreign Ownership
Accumulating
Market Heat
Cautious
Fundamentals (US)
P/E Ratio
24.98x
ROE
6.21%
P/B Ratio
1.52x
Dividend Yield
2.79%
Market Insight
The score sits in neutral territory (45/100). Waiting for a clearer signal may be warranted.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
Financial snapshot
CVS - CVS Health Corporation
EPS
3.79USD
Forward EPS
8.51USD
P/E
24.98x
Forward P/E
11.12x
P/B
1.52x
ROE
6.21%
ROA
2.97%
Operating margin
3.86%
Profit margin
1.18%
Revenue growth
7.10%
Earnings growth
188.80%
Dividend yield
2.79%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $106.10B | $100.43B | $105.69B | $102.87B | $98.92B | — |
| Gross profit | $15.75B | $15.62B | $13.57B | $13.81B | $13.59B | — |
| Operating income | $4.70B | $4.68B | $2.11B | $2.52B | $2.38B | — |
| Net income | $2.98B | $2.94B | $2.94B | -$3.98B | $1.02B | — |
| Basic EPS | — | 2.31 | 2.32 | -3.13 | 0.81 | 1.41 |
| Diluted EPS | — | 2.30 | 2.30 | -3.13 | 0.80 | 1.41 |
Estimates vs actuals
Next earnings
2026-10-28
EPS estimate
—
Revenue estimate
—
Last surprise
+39.36%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-28 | 1.61 | Not reported | — |
| 2026-08-05 | 1.85 | 2.58 | +39.36% |
| 2026-05-06 | 2.21 | 2.57 | +16.48% |
| 2026-02-10 | 1.00 | 1.09 | +9.38% |
| 2025-10-29 | 1.36 | 1.60 | +17.93% |
| 2025-07-31 | 1.46 | 1.81 | +23.85% |
| 2025-05-01 | 1.67 | 2.25 | +34.49% |
| 2025-02-12 | 0.92 | 1.19 | +29.56% |
| 2024-11-06 | 1.46 | 1.09 | -25.23% |
| 2024-08-07 | 1.73 | 1.83 | +5.95% |
| 2024-05-01 | 1.70 | 1.31 | -22.79% |
| 2024-02-07 | 1.99 | 2.12 | +6.59% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $9.6B | 0.14% |
| STATE STREET CORP | 2026-06-30 | $6.2B | 0.18% |
| BlackRock Inc. | 2024-06-30 | $5.9B | 0.13% |
| CITADEL ADVISORS LLC | 2026-06-30 | $497.9M | 0.06% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $45.6M | 0.06% |
| Bridgewater Associates, LP | 2026-06-30 | $45.6M | 0.19% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$116.04
Target range
$103.00 – $148.00
Implied upside
22.87%
Strong buy
6
Buy
18
Hold
3
Sell
0
Strong sell
0
Dividends
Annual yield
2.81%
Frequency
Quarterly
Recent payouts
- 2026-07-23$0.6650
- 2026-04-23$0.6650
- 2026-01-22$0.6650
- 2025-10-23$0.6650
Advertisement